Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

AIDS Treatment News Index, 2003

December 26, 2003

2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

You may find the articles listed below in the AIDS Treatment News Index of Articles, or search The Body.

A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z


TopicIssue #
Abacavir + tenofovir + 3TC failure393
Abbott raises Norvir price five fold397
Access for all, Thailand conference theme395
ADAP organizing388
ADAP Washington trip397
Aegis388
Africa Action390
Africa trials -- no drugs391
African-Americans and AIDS Conference388, 397
AIDS Treatment News online publication397
AIDS Treatment News396
Antibiotic-resistant staph388
Atazanavir (Reyataz) approved392
Bahamas antiretroviral prices, Clinton389
Biomedical research cuts392
Bush AIDS initiative388, 391
Buyers' club lists397
Cholesterol management394
Ciasullo, Eric, on returning to work395
Clinical Care Options for Hepatitis391
Clinical Care Options388
Clinton Foundation lowers Caribbean price389
Clinton Foundation, HAART 40 cents/day395
Cohen, Dr. Cal, on Retroviruses conf., pt. 1389
Cohen, Dr. Cal, on Retroviruses conf., pt. 2390
Co-trimoxazole for staph388
Counterfeit Procrit389
Deep salvage390
Drug development397
Efavirenz vs. nevirapine389
Emtriva (FTC) approved393
Export problem, WTO394
Federal policy problems392
Fosamprenavir approved395
FTC (Emtriva) approved393
Fundraising, online392
FUZEON (T-20)389
Glaxo research grants391
Global Fund to Fight AIDS, TB, and Malaria388
Grassroots organizing388
Heart disease guidelines394
Highly experienced patients390
HIV Insite388
HIV nutrition info for doctors391
HIV treatment guidelines, July393
HIV treatment guidelines, November 2003396
HIVandHepatitis.com388
Hoffmann-La Roche, T-20389
Huge price variations in generics391
IAS conference reports on Web393
International AIDS Society conf., Paris392
Lexiva (908, Fosamprenavir)389
Lexiva approved395
Medicaid cuts planned390
Medicaid organizing388
Medscape388
Microbicides391
MRSA388
NATAP388
Nelson Mandela on HIV treatment access393
Neuropathy treatment, new guidelines396
Nevirapine reduced maternal transmission394
Nevirapine toxicity389
Nevirapine vs. efavirenz389
Norvir price fivefold rise397
Paris conference reports on Web393
Pediatric HIV guidelines, November 2003396
Pharmaceutical company lobbying facts397
Pharmacy benefits managers, profit391
Philadelphia FIGHT391
Planetwork conference392
Pneumocystis still cause of death in U.S.391
Prevention policy problems392
Prices of drugs391
Prison Health News390
Prison skin infections388
Retroviruses conference, Web coverage388
Returning to work after disability395
Reyataz approved392
Safety net failure391
SARS Web information390
Save ADAP committee397
Search for a Cure, clinical trials forum395
Social network software, for fundraising392
Social Security disability definition392
Staph infection treatments388
Starting antiretroviral therapy389
Subscriptions to share396
T-20 cost389
TAC (Treatment Action Campaign)390
Tenofovir + ddI + 3TC failure395
Thailand conference 2004, deadlines395
The Body Web site388
Treatment Action Campaign390
Treatment interruption390, 394
Triglycerides management394
Trizivir arm stopped in trial390
UNAIDS report for 2003396
VaxGen's AIDSVAX trial389
World AIDS: $4.7 billion -- WorldCom: $35 billion396
World Trade Organization rules394
WORLD, women and HIV391
WTO rules limit access to poor countries394

Advertisement

ISSN # 1052-4207

Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.
 

Tools
 

Advertisement